ReviewFrontiers in immunology2026
The bidirectional role of neutrophils in the regulation of bone metabolism: a review of research progress and mechanism.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone homeostasis is maintained through a dynamic balance between osteoblast-mediated bone formation and osteoclast-mediated bone resorption. With the rapid development of osteoimmunology, increasing attention has been directed toward the role of immune cells in the regulation of bone metabolism. Neutrophils, as the most abundant innate immune cells in the bone marrow, are now recognized not only as key effectors of inflammation but also as important regulators of bone microenvironment homeostasis and bone remodeling. This review summarizes current advances in the understanding of neutrophil-mediated regulation of bone metabolism, focusing on their dual roles in osteogenesis and osteoclastogenesis. During the early stages of bone repair, neutrophils may facilitate bone regeneration by clearing necrotic debris, promoting angiogenesis, and modulating mesenchymal stem cells (MSCs) function. However, in pathological settings such as persistent inflammation, metabolic dysfunction, and aging, neutrophil dysregulation can suppress osteogenesis and enhance osteoclastogenesis through the release of inflammatory mediators, reactive oxygen species, and neutrophil extracellular traps (NETs), ultimately contributing to bone metabolic imbalance. Notably, NETs exhibit context-dependent effects in bone remodeling and may either support repair or aggravate bone destruction under different pathological conditions. Overall, neutrophils function as critical intermediates linking immune responses with bone remodeling. Their diverse effects on bone metabolism are largely determined by their activation status and the surrounding microenvironment. Elucidating the mechanisms underlying neutrophil-mediated regulation of bone metabolism may offer new insights and potential therapeutic targets for osteoporosis, inflammatory bone destruction, and impaired bone healing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.